Status:
COMPLETED
Effect of Valdecoxib Pretreatment on Pain and Secondary Hyperalgesia in Healthy Volunteers
Lead Sponsor:
Penn State University
Collaborating Sponsors:
Pfizer
National Institutes of Health (NIH)
Conditions:
Pain
Hyperalgesia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Tis study was designed to test the hypothesis that pretreatment with valdecoxib, prior to injury could reduce or prevent the development of secondary hyperalgesia around the area of primary injury. A ...
Eligibility Criteria
Inclusion
- healthy male of non-pregnant female; 18yo or older
- not currently taking NSAID
- able and willing to provide informed consent
- willing to avoid other NSAIDs in 24 hour period following study
- no known hypersentitivites or contraindications to NSAIDS, sulfonomides or capsaicin
Exclusion
- pregnant or breast feeding
- use of NSAIDS or other analgesic medications in past 7 days
- unwilling or unable to give informed consent
- contraindication to any study medication or other NSAID
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00260325
Start Date
August 1 2004
End Date
April 1 2006
Last Update
November 24 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State University College of Medicine
Hershey, Pennsylvania, United States, 17033